Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms. (2020)

First Author: Baumeister J
Attributed to:  Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-019-0629-z

PubMed Identifier: 31728053

Publication URI: http://europepmc.org/abstract/MED/31728053

Type: Journal Article/Review

Volume: 34

Parent Publication: Leukemia

Issue: 4

ISSN: 0887-6924